SEGALL BRYANT & HAMILL, LLC - FURIEX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
SEGALL BRYANT & HAMILL, LLC ownership history of FURIEX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$2,689,000
-40.5%
25,326
-51.2%
0.06%
+18.5%
Q1 2014$4,518,000
+105.6%
51,938
-0.7%
0.05%
+107.7%
Q4 2013$2,198,000
+90.0%
52,330
+99.0%
0.03%
-10.3%
Q3 2013$1,157,000
+29.3%
26,298
+0.1%
0.03%
+20.8%
Q2 2013$895,000
-9.2%
26,269
-0.1%
0.02%
-7.7%
Q1 2013$986,00026,2940.03%
Other shareholders
FURIEX PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 319,536$13,424,0009.48%
Global Alpha Capital Management Ltd. 67,120$2,996,0004.61%
Consonance Capital Management LP 648,829$27,257,0004.47%
Alistair Capital Management, L.L.C. 168,738$7,089,0003.18%
Artal Group S.A. 870,842$36,584,0001.31%
Breithorn Capital Management 48,058$2,019,0001.13%
THOMPSON SIEGEL & WALMSLEY LLC 600,615$25,232,0000.59%
FRANKLIN STREET ADVISORS INC /NC 52,325$2,198,0000.44%
Visium Asset Management, LP 312,698$13,136,0000.26%
AMERICAN CAPITAL MANAGEMENT INC 49,134$2,064,0000.26%
View complete list of FURIEX PHARMACEUTICALS INC shareholders